Alan Parsa is an Endocrinology/Metabolic physician affiliated with University of Hawaiʻi at Mānoa. OpenAlex indexes 67 publications with 1,959 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
58 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
58 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
69.3%GLP-1 receptor agonist22.6%Ozempic51%Trulicity31%Rybelsus9%Mounjaro5%Victoza 3-Pak5%Part D<11 patientsInsulin Analog15.8%Lantus Solostar25%Tresiba Flextouch U-10020%Novolog Flexpen19%Humalog Kwikpen U-10016%Toujeo Max Solostar9%Basaglar Kwikpen U-1008%Tresiba Flextouch U-2005%Part D<11 patients+ 9 more classes in this area
Hormonal (systemic)
17.3%l-Thyroxine11.6%Levothyroxine Sodium90%Synthroid10%Part D≥109 patientsThyroid Hormone Synthesis Inhibitor2.9%Methimazole100%Part D≥37 patients+ 3 more classes in this area
Cardiovascular
6.2%Statin1.9%Atorvastatin Calcium55%Simvastatin25%Rosuvastatin Calcium20%Part D<11 patientsNonsteroidal Mineralocorticoid-Receptor Antagonist1.7%Kerendia100%Part D≥13 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Unexpected Ischemia: A Case of Neonatal Ulcer After Umbilical Artery Catheter Calcium Gluconate Infusion
Plastic & Reconstructive Surgery Global Open
2025 - Prevalence Study of MASLD in Adolescent and Young Adult Pacific Islanders and Asians Living in Hawai’i
Journal of the Endocrine Society
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Todd Seto, MD
University of Hawaiʻi at Mānoa
Brian Issell, MD, FACP
University of Hawaiʻi at Mānoa
Naoky Tsai, MD
University of Hawaiʻi at Mānoa
Kore Liow, MD
University of Hawaiʻi at Mānoa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”